Point72 (DIFC)’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$54.6K Buy
6,074
+5,367
+759% +$47.1K ﹤0.01% 706
2025
Q2
$9.19K Sell
707
-210,341
-100% -$3.16M ﹤0.01% 1325
2025
Q1
$5.33M Buy
211,048
+59,410
+39% +$1.77M 0.22% 125
2024
Q4
$5.21M Buy
151,638
+148,333
+4,488% +$6.69M 0.19% 136
2024
Q3
$163K Buy
+3,305
New +$169K 0.01% 882
2024
Q2
Sell
-3,476
Closed -$179K 1848
2024
Q1
$179K Buy
+3,476
New +$171K 0.01% 980

Other funds holding RXST

Point72 (DIFC)'s RXST Position: Q3 2025 in Review

Point72 (DIFC) increased its RxSight (RXST) stake by 759% in Q3 2025, buying an estimated $47.1K and bringing the position to 6,074 shares worth $54.6K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Point72 (DIFC) first reported a position in RXST in Q1 2024 and has held it in 6 quarters since. The position peaked at $5.33M in Q1 2025. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Point72 (DIFC) held 6,074 shares of RxSight worth $54.6K as of Q3 2025.
  • Point72 (DIFC) bought 5,367 RxSight shares in Q3 2025, an estimated $47.1K.
  • RxSight made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #706 holding.
  • Point72 (DIFC) first reported a position in RxSight in Q1 2024 and has held it in 6 quarters since.
  • Point72 (DIFC)'s RxSight position peaked at $5.33M in Q1 2025.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.